Diabetic Neuropathy Market Assessment: Global Market Scenario

Diabetic neuropathy, also called diabetic nerve damage, is a common complication of diabetes in which nerves in the legs, feet, hands, arms, and other parts of the body are damaged due to effects of high blood sugar levels. The symptoms of diabetic neuropathy may include numbness, tingling and burning pain. Medications like pregabalin, duloxetine and gabapentin are prescribed to relieve neuropathic pain in patients with diabetes. Anti-seizure medications are also commonly used off-label to treat diabetic nerve pain symptoms. Topical patches and creams containing lidocaine are also indicated for localized pain relief. The increasing diabetes prevalence rate and growing geriatric population are majorly driving the demand for effective treatment options against diabetic neuropathy globally.

Get more insights on this topic: https://www.coherentmarketinsi....ghts.com/market-insi

The Global Diabetic Neuropathy Market is estimated to be valued at US$ 3626.38 mn in 2024 and is expected to exhibit a CAGR of 6.9% over the forecast period 2023 to 2030.